FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy, and deals with treatment of muscular mass loss. For this purpose, food product, which contains amino acid with branched chain (BCAA), BCAA precursor or BCAA metabolite, in combination with inhibitor of RNA-dependent proteinkynases (PKR) in efficient quantity.
EFFECT: ensuring efficient treatment of muscular mass loss in various diseases due to ability of BCAA and PKR to influence protein catabolism by various mechanisms and as a result supplement and enhance each other's ability to counteract protein catabolism.
18 cl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING RNA EXPRESSION IN CELL | 2018 |
|
RU2784654C2 |
| COMPOSITIONS CONTAINING AMINO ACIDS FOR APPLICATION WITHIN STROKE TREATMENT IN PATIENTS WITH DYSPHAGIA | 2015 |
|
RU2668373C1 |
| CELL BASED QUALITY CONTROL BIOASSAYS FOR NUTRICEUTICAL AND MEDICINAL PRODUCTS | 2013 |
|
RU2662358C2 |
| USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY | 2017 |
|
RU2806346C2 |
| PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS | 2018 |
|
RU2804280C2 |
| INTEGRATED STRESS PATHWAY PRODRUG MODULATORS | 2019 |
|
RU2824500C2 |
| METHOD TO ACCELERATE RECOVERY OF SKELETAL MUSCLES ATROPHY AFTER A LONG ALCOHOL INTOXICATION | 2014 |
|
RU2578463C1 |
| COMPOSITION FOR TREATING MUSCULAR ATROPHY | 2020 |
|
RU2814282C2 |
| EMPLOYMENT OF (R)-ARYLPROPIONIC ACIDS TO PREPARE DRUGS FOR TREATMENT OF HUMANS AND ANIMALS LIABLE TO BE THERAPEUTICALLY AFFECTED VIA NF-κB ACTIVATION INHIBITION | 2000 |
|
RU2250103C2 |
| NOVEL COMPOSITION CONTAINING AMINO ACIDS WITH BRANCHED SIDE CHAINS | 2020 |
|
RU2817963C2 |
